An on‐Demand Oxygen Nano‐vehicle Sensitizing Protein and Nucleic Acid Drug Augment Immunotherapy
Advanced Materials · 2025
DOI: 10.1002/adma.202409378 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Sidi Zhang und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute. Ren Ji Hospital School of Medicine, Shanghai Jiao Tong University, Sh…. Hauptthemen laut MEDLINE: Oxygen, Immunotherapy, Oligodeoxyribonucleotides, Drug Carriers. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shang Hai Sailing Program, Foundation of Shanghai Municipal Health Commission.
Abstract (Originalsprache)
Hypoxia severely limits the antitumor immunotherapy for breast cancer. Although efforts to alleviate tumor hypoxia and drug delivery using diverse nanostructures achieve promising results, the creation of a versatile controllable oxygen‐releasing nano‐platform for co‐delivery with immunostimulatory molecules remains a persistent challenge. To address this problem, a versatile oxygen controllable releasing vehicle PFOB@F127@PDA (PFPNPs) is developed, which effectively co‐delivered either protein drug lactate oxidase (LOX) or nucleic acids drug unmethylated cytosine‐phosphate‐guanine oligonucleotide (CpG ODNs). Upon photothermal heating, this platform triggered oxygen release, thereby augmenting LOX‐mediated lactate detection rates, and improving T cells infiltrating and cytokine expression. Moreover, under an oxygenated tumor microenvironment (TME), PFPNPs co‐delivered with CpG ODNs effectively reprogrammed the immunosuppressive TME by repolarizing macrophages to an M1‐like phenotype, promoting dendritic cells maturation, and increasing tumor‐infiltrating T cells while decreasing the ratio of regulatory T cells (Tregs). Our study demonstrated that this controlled oxygen‐releasing platform possessed adaptive drug‐loading capabilities to meet varied immunotherapeutic demands in clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute. Ren Ji Hospital School of Medicine, Shanghai Jiao Tong University, Shanghai, 200032, P. R. China.
- State Key Laboratory for Cancer Systems Regulation and Clinical Translation, Jiading District Central Medicine Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, Shanghai, 201800, P. R. China.
- Central Laboratory Ren Ji Hospital School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
- Allergy Department Ren Ji Hospital School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
- Department of Urology, Shanghai Pudong New Area People's Hospital, Shanghai, 201299, P. R. China.
ORCID-Profile: Peifeng Liu
Förderung
- National Natural Science Foundation of China
- Shang Hai Sailing Program
- Foundation of Shanghai Municipal Health Commission
- Medical Transformation Crossing Funding from Shanghai Jiao Tong University
- construction project-Chongming Whole population whole life cycle cluster clinical research Center construction
Zitieren
APA
Zhang, S., Wang, X., Chen, X., Shu, D., Lin, Q., Zou, H., Dong, J., Wang, B., Tang, Q., Li, H., Chen, X., Pu, J., Gu, B., & Liu, P. (2025). An on‐Demand Oxygen Nano‐vehicle Sensitizing Protein and Nucleic Acid Drug Augment Immunotherapy. Advanced Materials. https://doi.org/10.1002/adma.202409378
Vancouver
Zhang S, Wang X, Chen X, Shu D, Lin Q, Zou H, et al. An on‐Demand Oxygen Nano‐vehicle Sensitizing Protein and Nucleic Acid Drug Augment Immunotherapy. Advanced Materials. 2025. doi:10.1002/adma.202409378
BibTeX
@article{Zhang2025,
author = {Zhang, Sidi and Wang, Xinghui and Chen, Xiaojing and Shu, Duohuo and Lin, Quankun and Zou, Hanbing and Dong, Jialin and Wang, Bing and Tang, Qianyun and Li, Huishan and Chen, Xiaoxiang and Pu, Jun and Gu, Bin and Liu, Peifeng},
title = {An on‐Demand Oxygen Nano‐vehicle Sensitizing Protein and Nucleic Acid Drug Augment Immunotherapy},
journal = {Advanced Materials},
year = {2025},
doi = {10.1002/adma.202409378}
}
EUVIMED